- Home
- Clinical Trials
Obesity & Knee Osteoarthritis Studies Sydney DH 5
Obesity & Knee Osteoarthritis Studies
Darlinghurst Sydney
Join a clinical trial exploring groundbreaking preventions for Obesity & Knee Osteoarthritis
Description
What to expect
Study details
Ages
Open Ages
Duration
Varies
Compensation
Eligible participants will be reimbursed
Eligibility Criteria
You may qualify for this study if you:
- Have a BMI of 27 or higher
- Have a clinical diagnosis of Knee Osteoarthritis
- Can visit the Darlinghurst, Sydney Momentum clinic for appointments
Other eligibility criteria will apply
Locations
Description
Obesity is a complex, chronic condition defined by excessive body fat that can harm health and impact emotional wellbeing. It’s influenced by genetic, behavioural, and environmental factors and is a major contributor to knee osteoarthritis (OA); a degenerative joint disease that causes pain, stiffness, and reduced mobility. Excess weight increases stress and inflammation in the knee joints, accelerating cartilage breakdown and worsening OA symptoms. Together, these conditions can make everyday activities challenging and affect overall quality of life, highlighting the importance of managing both weight and joint health for long-term wellbeing.
Treatment for obesity and knee osteoarthritis often includes lifestyle changes, physiotherapy, medication, and, in some cases, surgery. However, many existing therapies focus on managing symptoms rather than addressing the underlying causes of both conditions.
What to expect
Momentum Clinical Research conducts research studies that test new potential treatments that aim to help achieve better outcomes for those affected by Obesity and Knee Osteoarthritis. Register your interest now to find out if you are eligible to participate in this study and help develop potential new treatment options.
All study treatments are free of charge and participants are paid for any study related costs.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.